Orsus Xelent Technologies Inc. carries a market capitalization of 600.00, placing it among publicly traded companies globally. Its enterprise value stands at 21.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 600.00 |
| Enterprise Value | 21.20M |
Orsus Xelent Technologies Inc. currently has 2.52M shares outstanding.
| Shares Outstanding | 2.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.67, and the price-to-book ratio stands at 0.83.
| PE Ratio | N/A |
| PS Ratio | 0.67 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | -56.14 |
| P/OCF Ratio | -56.14 |
On an enterprise value basis, Orsus Xelent Technologies Inc. trades at an EV/EBITDA multiple of 64.33 and an EV/FCF ratio of 15.76. The EV/Sales ratio of 1.12 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 73.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.12 |
| EV / EBITDA | 64.33 |
| EV / EBIT | 73.60 |
| EV / FCF | 15.76 |
Orsus Xelent Technologies Inc. maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.46, indicating elevated leverage, while an interest coverage ratio of -28.83 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.29 |
| Quick Ratio | 1.17 |
| Debt / Equity | 39.46 |
| Debt / EBITDA | -0.30 |
| Interest Coverage | -28.83 |
| Return on Equity (ROE) | -74.85 |
| Return on Assets (ROA) | -16.42 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 19.90 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 4.54M |
| Effective Tax Rate | N/A |
Orsus Xelent Technologies Inc.'s stock has gained approximately 100.00001% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 100.00001% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Orsus Xelent Technologies Inc. generated 18.90M in revenue and converted that into -17.54M in net income, yielding earnings per share of -6.96. EBITDA reached -33.56M, while operating income came in at -33.58M.
| Revenue | 18.90M |
| Gross Profit | 1.52M |
| Operating Income | -33.58M |
| Pretax Income | -13.00M |
| Net Income | -17.54M |
| EBITDA | -33.56M |
| EBIT | -33.58M |
| Earnings Per Share (EPS) | -6.96 |
Orsus Xelent Technologies Inc. holds 1.37M in cash and equivalents against 9.93M in total debt, resulting in a net debt position of 9.93M. Total book value stands at 15.17M, with working capital of 25.02M providing operational flexibility.
| Cash & Cash Equivalents | 1.37M |
| Total Debt | 9.93M |
| Net Debt | 9.93M |
| Equity (Book Value) | 15.17M |
| Book Value Per Share | 6.02 |
| Working Capital | 25.02M |
Orsus Xelent Technologies Inc. produced -225,000.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -225,000.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -225,000.00 |
| FCF Per Share | -0.09 |
Orsus Xelent Technologies Inc. operates with a gross margin of 8.06, reflecting its pricing power and cost economics. The operating margin of -177.69 and net profit margin of -92.80 provide insight into operational efficiency.
| Gross Margin | 8.06 |
| Operating Margin | -177.69 |
| Pretax Margin | -68.80 |
| Profit Margin | -92.80 |
| EBITDA Margin | -177.57 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -1.78 |
Orsus Xelent Technologies Inc.'s most recent stock split took place on April 28, 2011 with a 12:1 split ratio.
| Last Split Date | 4/28/2011 |
| Split Ratio | 12:1 |
Orsus Xelent Technologies Inc. posts an Altman Z-Score of -0.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.28 |